These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 13724820)

  • 1. The metabolism of 6-chloropurine-8-C14 in the rat.
    DUGGAN DE; TITUS E
    J Pharmacol Exp Ther; 1960 Dec; 130():375-82. PubMed ID: 13724820
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():245-50. PubMed ID: 13746610
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion of 6-chloropurine to its ribonucleotide by ascites tumor cells.
    Hampton A; Paterson AR
    Biochim Biophys Acta; 1966 Jan; 114(1):185-7. PubMed ID: 5936954
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the biosynthesis of purines de novo by 6-chloropurine and azaserine in sensitive and naturally resistant ascites cells.
    SARTORELLI AC; AKERS JR; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():238-44. PubMed ID: 13746609
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heterocyclic compounds in metabolism. VI. Determination of the conversion rate of C14-5-labeled purines in microorganisms].
    KORTE F; WEITKAMP H; SCHICKE HG
    Biochem Z; 1958; 329(6):458-62. PubMed ID: 13535599
    [No Abstract]   [Full Text] [Related]  

  • 6. Purine analogs in leukemia.
    Lamanna N; Weiss M
    Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on fluorinated pyrimidines. III. The metabolism of 5-fluorouracil-2-C14 and 5-fluoroorotic-2-C14 acid in vivo.
    CHAUDHURI NK; MONTAG BJ; HEIDELBERGER C
    Cancer Res; 1958 Apr; 18(3):318-28. PubMed ID: 13523598
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on OPSPA. II. Distribution and excretion of radioactivity following administration of OPSPA-C14 and OPSPA-P32 to the rat.
    MALLER RK; HEIDELBERGER C
    Cancer Res; 1957 May; 17(4):284-90. PubMed ID: 13427008
    [No Abstract]   [Full Text] [Related]  

  • 9. The incorporation of glycine-2-C14 into acid soluble nucleotide purines.
    EDMONDS MP; LEPAGE GA
    Cancer Res; 1955 Feb; 15(2):93-9. PubMed ID: 14352194
    [No Abstract]   [Full Text] [Related]  

  • 10. Antineoplastic activity of combinations of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Cancer Res; 1960 Feb; 20():198-203. PubMed ID: 14441824
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
    Wang L; Weinshilboum R
    Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The excretion of radioactivity following administration of tri-C14-ethylenimino-s-triazine in normal mice.
    GOLDENTHAL EI; NADKARNI MV; SMITH PK
    J Pharmacol Exp Ther; 1958 Apr; 122(4):431-41. PubMed ID: 13539769
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the duration of circulation in the blood and excretion in the urine of C14-labeled sarcolysin following intravenous administration to rabbits].
    NOVIKOVA MA; CHESTUKHIN AV
    Biull Eksp Biol Med; 1961 Aug; 52():56-9. PubMed ID: 13729778
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on OPSPA. III. Distribution and excretion of radioactivity following administration of OPSPA-C14 and OPSPA-P32 to humans.
    MALLER RK; MCIVER FA; HEIDELBERGER C
    Cancer Res; 1957 May; 17(4):291-5. PubMed ID: 13427009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inclusion of sarcolysin-C14 into protein fractions of cell nuclei and cytoplasm of normal and neoplastic tissues].
    NOVIKOVA MA
    Vopr Med Khim; 1960; 6():625-30. PubMed ID: 13729780
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on OPSPA. IV. Metabolism of OPSPA in the rat and human.
    MALLER RK; HEIDELBERGER C
    Cancer Res; 1957 May; 17(4):296-301. PubMed ID: 13427010
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of 4-amino-5-imidazolecarboxamide on the synergistic antineoplastic activity of 6-chloropurine and azaserine.
    Sartorelli AC; Booth BA
    Experientia; 1965 Aug; 21(8):457-8. PubMed ID: 5870913
    [No Abstract]   [Full Text] [Related]  

  • 18. Ferrocene-modified purines as potential electrochemical markers: synthesis, crystal structures, electrochemistry and cytostatic activity of (ferrocenylethynyl)- and (ferrocenylethyl)purines.
    Hocek M; Stepnicka P; Ludvík J; Císarová I; Votruba I; Reha D; Hobza P
    Chemistry; 2004 Apr; 10(8):2058-66. PubMed ID: 15079846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES.
    ELION GB; CALLAHAN S; RUNDLES RW; HITCHINGS GH
    Cancer Res; 1963 Sep; 23():1207-17. PubMed ID: 14070377
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding to DNA purine base and structure-activity relationship of a series of structurally related Ru(II) antitumor complexes: a theoretical study.
    Chen JC; Chen LM; Xu LC; Zheng KC; Ji LN
    J Phys Chem B; 2008 Aug; 112(32):9966-74. PubMed ID: 18630950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.